Trial record 1 of 1 for: NCT01131065
Previous Study | Return to List | Next Study
Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients
This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2013 by Grifols Biologicals Inc.
Instituto Grifols, S.A.
Information provided by (Responsible Party):
Grifols Biologicals Inc. ( Instituto Grifols, S.A. )
First received: May 25, 2010
Last updated: March 18, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||December 2013|
|Estimated Primary Completion Date:||December 2013 (Final data collection date for primary outcome measure)|